Back

Effectiveness of statins for primary prevention in the elderly - a propensity score matched cohort study

29 August 2025 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Drug therapy (1) Drug therapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor David Leibowitz

Hadassah-Hebrew University Medical Centre, Jerusalem (Israel)

7 More presentations in this session

Presentation thumbnail
The association between the response of lipid-lowering agents and monogenic variants of familiar hypercholesteremia in Taiwan
Professor P. Liu (Tainan, TW)
Abstract Slides Video
Presentation thumbnail
Prospective validation of a self-report-based model for coronary artery calcium screening and assessment of treatment gaps in lipid-lowering therapy.
Doctor E. Hagberg (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
BW-00112 targeting ANGPTL3 results in prolonged reductions in plasma triglycerides, LDL-C, and remnant-C in Chinese healthy subjects
Ms Y. Li (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Icosapent ethyl reduces CVD risk in cardiovascular-kidney-metabolic syndrome: REDUCE-IT CKM
Professor M. Miller (Philadelphia, US)
Abstract Slides Video
Presentation thumbnail
PCSK-9-inhibitor therapy improves endothelial function in patients with coronary artery disease
Doctor A. Bosch (Erlangen, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Drug therapy (1)

The Event

Event poster

ESC Congress 2025

29 August 2025 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Association of lipid-lowering drug treatment with all-cause and cardiovascular mortality among people aged 75 years and above without cardiovascular disease: evidence from a cohort study
thumbnail
Congress Presentation
Combination of moderate-intensity statins and ezetimibe versus high-intensity statins alone for primary prevention of cardiovascular events
thumbnail
Congress Presentation
Lipid lowering therapy in patients aged 90 years or older with acute myocardial infarction:a multicenter cohort study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources